Background
==========

Copy Number Variations (CNVs) i.e. deletions and amplifications, are an essential part of normal human variability \[[@B1]\]. Specific CNV events have also been linked to various human diseases \[[@B2]\], including cancer \[[@B3],[@B4]\] autism \[[@B5],[@B6]\] and schizophrenia \[[@B7]\]. Historically, large CNV events can be observed using FISH \[[@B8]\] but systematic, genome-wide discovery of CNVs started with microarray-based methods \[[@B9]-[@B11]\] which can detect events down to 1 kb resolution. As with all hybridization based approaches, these methods are blind in repetitive and low complexity regions of the genome where probes cannot be designed. High throughput sequencing with next-generation technologies have enabled CNV detection at higher resolution (i.e. down to smaller event size), in whole-genome shotgun datasets \[[@B12]-[@B14]\]. However, despite decreasing costs, deep-coverage (≥ 25×) whole-genome data is still prohibitively expensive for routine sequencing of hundreds of samples, and in low-coverage (2-6× base coverage) datasets detection sensitivity and resolution is limited to long genomic events \[[@B1]\].

Targeted DNA capture technologies combined with high-throughput sequencing now provide a reasonable balance between coverage and sequencing cost in a substantial portion of the genome, and full-exome sequencing projects are presently collecting ≥ 25× average sequence coverage in thousands of samples. CNV events in exonic regions are important because the deletions of one or both copies, or amplifications affecting exons, are likely to incur phenotypic consequences.

Current algorithms for detecting CNVs in whole-genome shotgun sequencing data use one of four signals as evidence for an event: (1) aberrantly mapped mate-pair reads (RP or read pair methods); (2) split-read mapping positions (SR); (3) *de novo* assembly (AS); and (4) a significant drop or increase of mapped read depth (RD methods). Unfortunately, these methods are not generally applicable for CNV detection in capture sequence data without substantial modifications. SR, RP, and AS based methods are sensitive only to CNVs in which mapped reads or fragments span the event breakpoint (s). In the case of exon capturing data, this restricts detection to CNV events where at least one breakpoint falls in a targeted exon. RD based methods suffer from large fluctuations of sequence coverage stemming from variability in probe-specific hybridization affinities across different capture targets (in this case: exons) and sets of such targets (in our case: genes), and from the over-dispersion of the read coverage distribution in the same target across different samples. Presumably because of the technical challenges, and despite the importance of deletion or amplification events within exons, there are currently no reported CNV detection algorithms for targeted DNA capture based exon-sequencing data (with the exception of methods for tumor-normal datasets \[[@B15]\] where the read depth measured in the normal sample can be used for normalization -- signal not available in the case of population sequencing).

In this study, we set out to develop a CNV detection algorithm for capture sequencing data. This algorithm is based on RD measurement, and detects samples with non-normal copy number in the capture target regions. As participants of the 1000 Genomes Project, we took part in the data analysis of the "Exon Sequencing Pilot" dataset \[[@B16]\], where 12,475 exons from over 900 genes were targeted and sequenced with a variety of DNA capture and sequencing technologies.

Results and discussion
======================

Brief algorithmic overview
--------------------------

Our algorithm is an extended version of RD-based CNV detection that aims to mitigate the vast target-to-target (and consequently gene-to-gene) heterogeneity of read coverage by normalization procedures roughly corresponding to those employed in CNV detection methods from microarray hybridization intensity data. The overall workflow of our method is shown in Figure [1](#F1){ref-type="fig"} and described in greater detail in the Methods section. For a given gene in a given sample (we will use the abbreviation GSS: Gene-Sample Site throughout the paper), we define the read depth as the number of uniquely mapped reads whose 5' end falls within any of the targeted exons within that gene. We compare this measurement with an expected read depth (Eq. 2, Methods), based on a "gene affinity" calculated from measured read depth for that gene across all samples (to account for across-target read coverage variance due to target-specific hybridization), and the overall read depth for the sample (to account for the variance of read coverage due to the overall sequence quantity collected for the sample under examination). We then use a Bayesian scheme to determine whether the measured coverage is consistent with normal copy number (e.g. CN = 2 for autosomes), or aberrant copy number (i.e. homozygous deletion: CN = 0, heterozygous deletion: CN = 1, or amplification: CN \> 2). We have included two algorithmic variants: One is suitable for CNV events that occur at a low allele frequency (i.e. in a small fraction of the samples), and the other for capturing higher-frequency deletion events (see Methods).

![**Workflow of the CNV detection method. A**. Median Read Depth (MRD) is calculated for each sample, as a measure of sample coverage (NA18523 shown). **B**. The gene affinity is estimated for each gene as the slope of the least-square-error linear fit between MRD and RD for that gene (TRIM33 shown). **C**. Example of observed (magenta) and expected (green) read depth for three samples and four genes. The observed read depths were roughly half of the expected values for genes TRIM33 and NRAS, in sample NA18523, and detected as deletions.](1471-2105-13-305-1){#F1}

Dataset
-------

In this study we analyzed the exon capture sequencing dataset collected by the 1000 Genomes Project Exon Sequencing Pilot, including 931 genes processed with Agilent liquid-phase and Nimblegen solid-phase capture methods, and sequenced from 697 individuals with Illumina paired-end and/or 454 technologies. The samples in the dataset have been sequenced by four different data collection centers (Washington University, WU; Wellcome Trust Sanger Institute, SC; Broad Institute, BI; and Baylor College of Medicine, BCM) using different pairings of capture and sequencing technologies (Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}). As our method relies on an estimate of the gene-specific hybridization affinity, it requires that such affinities are consistent across all samples analyzed simultaneously. According to Principal Component Analysis of the observed read depths, (Figure [2](#F2){ref-type="fig"}A, see Methods), target and genes affinities are inconsistent across data from different centers, and therefore we analyzed each dataset separately. We only considered datasets with at least 100 samples (SC, BI, BCM) so we can obtain sufficient sample statistics across genes. After filtering out genes and samples that didn't meet our minimum read depth requirements (see Methods), we were left with the following datasets: SC (862 genes in 106 individuals sequenced with Illumina), BI (739 genes in 110 samples sequenced with Illumina), and BCM (439 genes in 349 samples sequenced with 454) (Table [1](#T1){ref-type="table"}). The number of genes that passed our filters was substantially lower in the BCM dataset both due to lower overall 454 coverage (see below), and because the longer 454 reads result in lower RD (fewer reads) when compared to shorter Illumina reads, even at equivalent base coverage.

###### 

Properties of datasets from different sequencing centers

                                                                           **SC**        **BCM**      **BI**        **WU**
  ------------------------------------------------------------------------ ------------- ------------ ------------- ------------
  **Total sample count**                                                   117           352          161           93
  **Sample count after quality control**                                   106           349          110           82
  **Technology**                                                           Illumina      454          Illumina      Illumina
  **Duplicate rate**                                                       0.21          0.30         0.50          0.72
  **Mapping quality (mean)**                                               50            33           45            51
  **Base coverage(mean ± standard deviation)**                             56 ± 34       23 ± 12      70 ± 61       29 ± 9
  **Read depth per gene(mean ± standard deviation)**                       2309 ± 3166   106 ± 171    1329 ± 2053   977 ± 1382
  **MRD(mean ± standard deviation)**                                       1710 ± 1073   97 ± 52      1070 ± 803    599 ± 164
  **Number of exons**                                                      8174          8174         8174          8174
  **Exons overlapped with segmental duplication regions**                  458 (5.6%)    458 (5.6%)   458 (5.6%)    458 (5.6%)
  **Number of genes (passing QC)**                                         862           439          739           1
  **Genes overlapped with segmental duplication regions**                  29 (3.3%)     11(2.5%)     23(3.1%)      0(0.0%)
  **Over-dispersion factor(mean ± standard deviation)**                    7.9 ± 8.2     2.1 ± 1.1    6.4 ± 5.5     N/A
  **Quality index(mean ± standard deviation)**                             9.4 ± 8.8     5.5 ± 2.3    7.6 ± 5.6     N/A
  **Expected detection sensitivity based on quality index**                0.46          0.20         0.41          N/A
  **Number of calls*h*= 0.65 either with or without a neighboring call**   36            4            56            N/A
  **Number of calls*h*= 0.1 either with a neighboring call**               17            0            11            N/A

###### 

Data characteristized by sequencing center and population

                                    **SC**                                                    
  --------------------------------- --------- --------- --------- --------- --------- ------- ---------
  **Number of samples**             18        14                  9                   51      14
  **Male/Female**                   9/9       5/9                 5/4                 24/27   2/12
  **Average read depth per gene**   1679      1701                1597                1617    1865
  **Read length**                   36        36                  36                  36      36
                                    **BCM**                                                   
                                    **CEU**   **CHB**   **CHD**   **JPT**   **LWK**           **YRI**
  **Number of samples**             40        62        78        16        108               45
  **Male/Female**                   20/20     15/47     38/40     5/11      51/57             22/23
  **Average read depth per gene**   178       131       171       243       128               165
  **Read length**                   258       323       339       300       336               322
                                    **BI**                                                    
                                    **CEU**   **CHB**   **CHD**   **JPT**                     **YRI**
  **Number of samples**             16        13        28        34                          19
  **Male/Female**                   9/7       11/2      12/16     16/18                       12/7
  **Average read depth per gene**   1623      1631      1675      1104                        1612
  **Read length**                   73        75        74        75                          76

Population abbreviations:

CEU -- Utah residents with Northern and Western European ancestry.

CHB -- Han Chinese in Beijing.

CHD -- Chinese in Denver, Colorado.

JPT -- Japanese in Tokyo, Japan.

LWK -- Luhya in Webuye, Kenya.

TSI -- Toscans in Italy.

YRI -- Yoruba in Ibadan, Nigeria.

![**Data characteristics for the 1000 genomes exon sequencing pilot datasets. A**. Principal component analysis of a "mixed" read depth matrix built with data from 3 different sequencing centers, SC (Wellcome Trust Sanger Institute), BI (Broad Institute) and BCM (Baylor College of Medicine). Each sample is represented as a point in the plot, with the first principal component plotted vs. the second principal component. Samples from different sequencing centers cluster separately from each other within this space, suggesting significant differences in the gene affinities among these three datasets. **B**. Distributions of MRD for each of the BCM, BI and SC samples **C**. Histogram of RD across all GSSs in the three datasets. **D**. Histogram of gene affinities across genes within each of the three datasets. **E**. Distributions of the RD over-dispersion factor (ODF) in our data.](1471-2105-13-305-2){#F2}

Sample coverage and gene affinities
-----------------------------------

As a metric of coverage for each sample, we calculated the sample-specific median gene RD, referred to as "Median Read Depth" (MRD); see Figure [1](#F1){ref-type="fig"}A and Methods. MRD was highest for the SC samples (1,710 ± 1,073, median 1,491 reads/gene; data presented as mean±standard deviation), see Figure [2](#F2){ref-type="fig"}B. MRD was somewhat lower for the BI samples (1,070 ± 803, median 860 reads/gene), and much lower in the BCM dataset (97 ± 52, median 87 reads/gene). As mentioned above, RD (distributed as in Figure [2](#F2){ref-type="fig"}C) is not determined by base coverage alone. Base coverage was highest in the BI data (70 ± 61, median 56 reads/base), followed by SC (56 ± 34, median 50 reads/base). The much lower RD in the 454 reads from BCM corresponds to only somewhat lower base coverage (23 ± 12, median 21 reads/base).

For each target we define a quantity, the "target affinity", intended to describe the number of reads (RD) being mapped to a given target, relative to the sample-specific MRD over all capture targets. Analogously, we define the gene-specific affinity as the ratio of the number of reads (RD) mapped to the targets (exons) belonging to that gene and the gene-specific MRD for that same sample (see Methods, Figure [2](#F2){ref-type="fig"}D). In general, tighter distributions of affinities, with mean and median as close to 1 as possible, are desirable because these correspond to more even target coverage. The observed gene affinities for our datasets (Figure [2](#F2){ref-type="fig"}D) were as follows: SC (1.40 ± 1.43, median 1.04), BI (1.58 ± 1.59, median 1.20), and BCM (2.63 ± 3.03, median 1.73). Because of the more favorable gene affinities, we used the SC data as our primary dataset for method development and experimental validations.

CNV candidates detected in the data
-----------------------------------

According to our Bayesian detection scheme, we call a heterozygous deletion event in a gene if the posterior probability value of CN = 1, i.e. P(CN=1 \| RD) ≥ *h* where *h* is a pre-defined probability cutoff value. Similarly, a homozygous deletion is where P(CN=0 \| RD) ≥ *h*. Although we detected both deletions and amplifications in the analyzed datasets, deletion events (even when in a heterozygous state) provide easier detectable signal than amplifications. For this reason we only discuss deletion events here and report candidate amplifications in Table [3](#T3){ref-type="table"}.

###### 

Gene duplication calls in the SC dataset

  **Population**   **Sample**   **Gene name**   **Gene function**                                                            **Chr**   **Start \[bp\]**   **End \[bp\]**   **Posterior probablity**   ***RD***~**observed**~   ***RD***~**expected**~
  ---------------- ------------ --------------- ---------------------------------------------------------------------------- --------- ------------------ ---------------- -------------------------- ------------------------ ------------------------
  CEU              NA12348      CD300LB         CD300 molecule-like family member b                                          17        70030472           70039195         1.000                      638                      420
  TSI              NA20533      CLDN10          claudin 10                                                                   13        95003009           95028269         1.000                      2108                     1582
  CHB              NA18526      SNRNP27         small nuclear ribonucleoprotein 27 kDa (U4/U6.U5)                            2         69974621           69977184         1.000                      530                      383
  CHB              NA18532      CES1            carboxylesterase 1 (monocyte/macrophage serine esterase 1)                   16        54401930           54424468         1.000                      501                      337
  TSI              NA20752      NOM1            nucleolar protein with MIF4G domain 1                                        7         156435193          156455158        1.000                      1335                     966
  TSI              NA20796      AHNAK           AHNAK nucleoprotein                                                          11        62040792           62059238         1.000                      7330                     5169
  TSI              NA20796      ZNF264          zinc finger protein 264                                                      19        62408577           62416161         0.999                      1276                     888
  TSI              NA20801      GPR128          G protein-coupled receptor 128                                               3         101811391          101896535        0.998                      14747                    8265
  TSI              NA20772      STX16           syntaxin 16                                                                  20        56660469           56684753         0.998                      2101                     1605
  TSI              NA20769      MRPS6           mitochondrial ribosomal protein S6                                           21        34419511           34436770         0.998                      1585                     1203
  TSI              NA20774      ELAVL4          ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D)   1         50383216           50439437         0.998                      782                      567
  TSI              NA20804      CYP2A13         cytochrome P450, family 2, subfamily A, polypeptide 13                       19        46291375           46293686         0.997                      1289                     984
  TSI              NA20774      CREB5           cAMP responsive element binding protein 5                                    7         28494318           28825421         0.996                      1435                     954
  TSI              NA20796      ZNF32           zinc finger protein 32                                                       10        43459504           43461587         0.996                      911                      646
  TSI              NA20520      C6orf145        chromosome 6 open reading frame 145                                          6         3668852            3683381          0.995                      2015                     1601
  CEU              NA12348      GDNF            glial cell derived neurotrophic factor                                       5         37851510           37870647         0.994                      306                      217
  CHB              NA18561      PSMB4           proteasome (prosome, macropain) subunit, beta type, 4                        1         149638688          149640730        0.986                      3461                     2216
  CEU              NA12546      DAZAP2          DAZ associated protein 2                                                     12        49920394           49922509         0.985                      2265                     1651
  TSI              NA20752      AATF            apoptosis antagonizing transcription factor                                  17        32380539           32488077         0.976                      1157                     843
  CEU              NA12749      PAQR5           progestin and adipoQ receptor family member V                                15        67439474           67483215         0.976                      1684                     1239
  TSI              NA20769      BCL2L11         BCL2-like 11 (apoptosis facilitator)                                         2         111597794          111638279        0.965                      1813                     1435
  TSI              NA20804      PILRA           paired immunoglobin-like type 2 receptor alpha                               7         99809603           99835466         0.909                      962                      752
  TSI              NA20589      C8orf85         chromosome 8 open reading frame 85                                           8         118019664          118024121        0.903                      147                      91
  TSI              NA20752      CCKAR           cholecystokinin A receptor                                                   4         26092358           26100987         0.902                      712                      532
  JPT              NA18973      HBG2            hemoglobin, gamma G                                                          11        5278820            5523329          0.901                      4151                     3094
  TSI              NA20774      HIPK1           homeodomain                                                                  1         114298778          114317657        0.900                      2374                     1626
  TSI              NA20774      ODC1            ornithine decarboxylase 1                                                    2         10498301           10502609         0.897                      1489                     935
  TSI              NA20796      STBD1           starch binding domain 1                                                      4         77446947           77450177         0.885                      978                      664
  TSI              NA20589      CRIPAK          cysteine-rich PAK1 inhibitor                                                 4         1378300            1379640          0.877                      76                       38
  YRI              NA19189      PSMB4           proteasome (prosome, macropain) subunit, beta type, 4                        1         149638688          149640730        0.853                      2622                     2090
  TSI              NA20774      STX16           syntaxin 16                                                                  20        56660469           56684753         0.811                      949                      704
  JPT              NA18980      CES1            carboxylesterase 1 (monocyte/macrophage serine esterase 1)                   16        54401930           54424468         0.788                      1679                     1036
  TSI              NA20774      PAQR5           progestin and adipoQ receptor family member V                                15        67439474           67483215         0.788                      1048                     676
  CHB              NA18561      CRNN            cornulin                                                                     1         150648694          150651333        0.778                      4845                     3172
  TSI              NA20774      DKK4            dickkopf homolog 4 (Xenopus laevis)                                          8         42350775           42353720         0.760                      493                      362
  TSI              NA20589      NOM1            nucleolar protein with MIF4G domain 1                                        7         156435193          156455158        0.740                      1052                     801
  TSI              NA20769      RNF122          ring finger protein 122                                                      8         33525813           33535831         0.734                      2574                     2004
  TSI              NA20796      ZNF521          zinc finger protein 521                                                      18        20896674           21184908         0.721                      3536                     2738
  TSI              NA20769      VLDLR           very low density lipoprotein receptor                                        9         2625453            2631499          0.676                      2092                     1624

Using a cutoff value *h*= 0.65, we detected deletion 96 events in the three datasets (36 in SC, 56 in BI, and 4 in BCM), all heterozygous deletions (Table [4](#T4){ref-type="table"}, Table [5](#T5){ref-type="table"} and Table [6](#T6){ref-type="table"}). The top ranked deletions are shown in Figure [3](#F3){ref-type="fig"}A. Most of the events were found in the Tuscan population, which constituted about half of the sample set. 10 of 36 gene deletions in the SC dataset were found in two samples (NA18523 and NA20533), clustered in a contiguous string of deleted genes extending approximately 3 Mb on chromosome 1 and 17, respectively, a genomic deletion event that we were also able to find in the 1000 Genomes Project whole-genome Low Coverage Pilot data \[[@B16]\] from the same samples (data not shown).

###### 

Gene deletion calls in the SC dataset

  **Population**   **Sample**   **Gene name**   **Gene function**                                                                      **Chr**   **Start \[bp\]**   **End \[bp\]**   **Posterior probability**   ***RD***~**observed**~   ***RD***~**expected**~
  ---------------- ------------ --------------- -------------------------------------------------------------------------------------- --------- ------------------ ---------------- --------------------------- ------------------------ ------------------------
  YRI              NA18523      BCL2L15         BCL2-like 15                                                                           1         114225268          114231520        1.000                       533                      1158
  YRI              NA18523      HIPK1           homeodomain interacting protein kinase 1                                               1         114298778          114317657        1.000                       2539                     5272
  TSI              NA20533      GLOD4           glyoxalase domain containing 4                                                         17        610163             632245           1.000                       1322                     2295
  TSI              NA20533      C1QBP           complement component 1, q subcomponent binding protein                                 17        5277059            5282317          1.000                       793                      1416
  TSI              NA20533      C17orf91        chromosome 17 open reading frame 91                                                    17        1562414            1563890          1.000                       369                      574
  YRI              NA18523      NRAS            neuroblastoma RAS viral (v-ras) oncogene homolog                                       1         115052679          115060304        1.000                       702                      1462
  YRI              NA18523      TRI3            tripartite motif-containing 33                                                         1         114741793          114808533        1.000                       2610                     5225
  TSI              NA20533      TRPV3           transient receptor potential cation channel, subfamily V, member 3                     17        3363961            3404894          1.000                       3365                     5275
  TSI              NA20774      PTMAP1          prothymosin, alpha pseudogene 1 (gene sequence 26)                                     6         30725671           30728671         1.000                       132                      260
  TSI              NA20796      SNRNP27         small nuclear ribonucleoprotein 27 kDa (U4/U6.U5)                                      2         69974621           69977184         0.998                       105                      194
  TSI              NA20807      HIST1H2BC       histone cluster 1, H2bc                                                                6         26231731           26232111         0.998                       42                       90
  TSI              NA20772      ULBP1           UL16 binding protein 1                                                                 6         150331436          150332954        0.997                       104                      205
  TSI              NA20807      CYP2A13         cytochrome P450, family 2, subfamily A, polypeptide 13                                 19        46291375           46293686         0.996                       126                      204
  YRI              NA18508      PTMAP1          prothymosin, alpha pseudogene 1 (gene sequence 26)                                     6         30725671           30728671         0.992                       145                      230
  CEU              NA07000      PSG8            pregnancy specific beta-1-glycoprotein 8                                               19        47950287           47960273         0.990                       29                       70
  CEU              NA11893      PSG8            pregnancy specific beta-1-glycoprotein 8                                               19        47950287           47960273         0.985                       43                       86
  TSI              NA20771      PTMAP1          prothymosin, alpha pseudogene 1 (gene sequence 26)                                     6         30725671           30728671         0.980                       533                      862
  TSI              NA20773      CCK             cholecystokinin                                                                        3         42274594           42280126         0.971                       282                      474
  CEU              NA07000      HMGN4           high mobility group nucleosomal binding domain 4                                       6         26653414           26653686         0.966                       68                       132
  CEU              NA12749      HMGN4           high mobility group nucleosomal binding domain 4                                       6         26653414           26653686         0.966                       156                      286
  TSI              NA20772      AIF1            allograft inflammatory factor 1                                                        6         31692086           31692262         0.964                       51                       124
  CEU              NA12348      DUSP10          dual specificity phosphatase 10                                                        1         219942377          219946216        0.962                       155                      242
  YRI              NA18508      ULBP1           UL16 binding protein 1                                                                 6         150331436          150332954        0.941                       40                       79
  YRI              NA18523      PPM1J           protein phosphatase, Mg2+/Mn2+ dependent, 1 J                                          1         113056116          113057756        0.891                       560                      924
  TSI              NA20807      POU5F1          POU class 5 homeobox 1                                                                 6         31240884           31241803         0.891                       124                      193
  TSI              NA20772      SERPINA11       serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11   14        93978696           93984864         0.889                       786                      1243
  CEU              NA07000      KRT18P19        keratin 18 pseudogene 19                                                               12        51630379           51632393         0.887                       85                       174
  CEU              NA12348      ULBP1           UL16 binding protein 1                                                                 6         150331436          150332954        0.879                       49                       88
  YRI              NA18523      RHOC            ras homolog gene family, member C                                                      1         113054308          113055529        0.867                       557                      955
  CEU              NA12348      STBD1           starch binding domain 1                                                                4         77446947           77450177         0.839                       246                      395
  CEU              NA07000      POU5F1          POU class 5 homeobox 1                                                                 6         31240884           31241803         0.823                       106                      169
  CEU              NA12749      SNRNP27         small nuclear ribonucleoprotein 27 kDa (U4/U6.U5)                                      2         69974621           69977184         0.775                       142                      216
  TSI              NA20752      POU5F1          POU class 5 homeobox 1                                                                 6         31240884           31241803         0.723                       76                       142
  TSI              NA20807      HIST1H2BO       histone cluster 1, H2bo                                                                6         27969220           27969600         0.723                       48                       88
  TSI              NA20589      POU5F1          POU class 5 homeobox 1                                                                 6         31240884           31241803         0.697                       61                       117
  TSI              NA20786      NPSR1           neuropeptide S receptor 1                                                              7         34884213           34884321         0.678                       51                       88

###### 

Gene deletion calls in the BI dataset

  **Population**   **Sample**   **Gene name**   **Gene function**                                                        **Chr**   **Start \[bp\]**   **End \[bp\]**   **Posterior probability**   ***RD***~**observed**~   ***RD***~**expected**~
  ---------------- ------------ --------------- ------------------------------------------------------------------------ --------- ------------------ ---------------- --------------------------- ------------------------ ------------------------
  CHD              NA18695      TPM3            tropomyosin 3                                                            1         152396739          152422219        1.000                       166                      337
  JPT              NA19066      TPM3            tropomyosin 3                                                            1         152396739          152422219        1.000                       169                      288
  CHD              NA18687      RPL27A          ribosomal protein L27a                                                   11        8661325            8663929          1.000                       93                       182
  JPT              NA18983      POU5F1          POU class 5 homeobox 1                                                   6         31240357           31241803         1.000                       122                      256
  JPT              NA19066      POU5F1          POU class 5 homeobox 1                                                   6         31240357           31241803         1.000                       166                      318
  JPT              NA19066      RPL27A          ribosomal protein L27a                                                   11        8661325            8663929          1.000                       106                      203
  CHD              NA18687      TPM3            tropomyosin 3                                                            1         152396739          152422219        1.000                       155                      258
  CHD              NA18687      POU5F1          POU class 5 homeobox 1                                                   6         31240357           31241803         1.000                       156                      285
  JPT              NA19054      TPM3            tropomyosin 3                                                            1         152396739          152422219        1.000                       135                      230
  CHD              NA18695      POU5F1          POU class 5 homeobox 1                                                   6         31240357           31241803         1.000                       194                      371
  JPT              NA18960      SETD8           SET domain containing (lysine methyltransferase) 8                       12        122441130          122455574        1.000                       221                      347
  CHD              NA18164      RPL27A          ribosomal protein L27a                                                   11        8661325            8663929          1.000                       129                      223
  JPT              NA19054      POU5F1          POU class 5 homeobox 1                                                   6         31240357           31241803         1.000                       130                      254
  CHD              NA18695      SETD8           SET domain containing (lysine methyltransferase) 8                       12        122441130          122455574        1.000                       142                      309
  CHD              NA18695      RPL27A          ribosomal protein L27a                                                   11        8661325            8663929          1.000                       128                      238
  CHD              NA18695      AKR1B1          aldo-keto reductase family 1, member B1 (aldose reductase)               7         133778020          133787045        1.000                       310                      554
  CHD              NA18164      HAX1            HCLS1 associated protein X-1                                             1         152512874          152514801        1.000                       214                      339
  CHD              NA18687      SETD8           SET domain containing (lysine methyltransferase) 8                       12        122441130          122455574        1.000                       125                      237
  JPT              NA19054      HFE             hemochromatosis                                                          6         26201326           26202433         1.000                       56                       122
  JPT              NA18983      RPL27A          ribosomal protein L27a                                                   11        8661325            8663929          0.990                       95                       164
  JPT              NA18983      TPM3            tropomyosin 3                                                            1         152396739          152422219        0.990                       147                      232
  JPT              NA19561      TRIM55          tripartite motif-containing 55                                           8         67202058           67209944         0.990                       119                      193
  CHD              NA18687      RBMS1           RNA binding motif, single stranded interacting protein 1                 2         160840394          160932124        0.990                       334                      575
  CHB              NA18757      CRIPAK          cysteine-rich PAK1 inhibitor                                             4         1378300            1379640          0.990                       327                      669
  JPT              NA19054      PSAT1           phosphoserine aminotransferase 1                                         9         80109471           80113319         0.980                       140                      253
  JPT              NA19066      PSAT1           phosphoserine aminotransferase 1                                         9         80109471           80113319         0.980                       190                      317
  CHD              NA18164      TPM3            tropomyosin 3                                                            1         152396739          152422219        0.980                       209                      317
  JPT              NA19568      OR8A1           olfactory receptor, family 8, subfamily A, member 1                      11        123945175          123946141        0.980                       471                      764
  JPT              NA19066      RAN             RAN, member RAS oncogene family                                          12        129923334          129926424        0.980                       229                      462
  CHD              NA18695      KLHL12          kelch-like 12                                                            1         201128284          201160913        0.970                       767                      1358
  JPT              NA19066      SETD8           SET domain containing (lysine methyltransferase) 8                       12        122441130          122455574        0.970                       154                      265
  JPT              NA19066      RPS15A          ribosomal protein S15a                                                   16        18706886           18707936         0.960                       83                       161
  CHD              NA18695      RPS15A          ribosomal protein S15a                                                   16        18706886           18707936         0.960                       88                       188
  CHD              NA18687      KLHL12          kelch-like 12                                                            1         201128284          201160913        0.960                       621                      1041
  JPT              NA18983      SETD8           SET domain containing (lysine methyltransferase) 8                       12        122441130          122455574        0.960                       120                      213
  JPT              NA18983      DCTN5           dynactin 5 (p25)                                                         16        23560365           23585966         0.960                       177                      298
  JPT              NA18983      EIF2B5          eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82 kDa   3         185500333          185509372        0.940                       856                      1482
  CHD              NA18687      ARG2            arginase, type II                                                        14        67187855           67187951         0.940                       28                       62
  CHD              NA18695      PSAT1           phosphoserine aminotransferase 1                                         9         80109471           80113319         0.930                       221                      371
  CHD              NA18695      RBMS1           RNA binding motif, single stranded interacting protein 1                 2         160840394          160932124        0.900                       442                      750
  JPT              NA19561      OR8A1           olfactory receptor, family 8, subfamily A, member 1                      11        123945175          123946141        0.890                       254                      466
  YRI              NA19247      TIMM8B          translocase of inner mitochondrial membrane 8 homolog B (yeast)          11        111461229          111462657        0.880                       40                       89
  CHD              NA18164      POU5F1          POU class 5 homeobox 1                                                   6         31240357           31241803         0.850                       226                      349
  CHD              NA18164      KLHL12          kelch-like 12 (Drosophila)                                               1         201128284          201160913        0.800                       803                      1276
  CHD              NA18164      SETD8           SET domain containing (lysine methyltransferase) 8                       12        122441130          122455574        0.790                       181                      291
  CHD              NA18687      RPS15A          ribosomal protein S15a                                                   16        18706886           18707936         0.790                       81                       144
  JPT              NA19066      EIF2B5          eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82 kDa   3         185500333          185509372        0.780                       1137                     1840
  JPT              NA19568      GABARAPL2       GABA(A) receptor-associated protein-like 2                               1         157676173          157676631        0.760                       254                      476
  JPT              NA19560      OR8A1           olfactory receptor, family 8, subfamily A, member 1                      11        123945175          123946141        0.750                       614                      1119
  JPT              NA19058      RPL27           ribosomal protein L27                                                    17        38404294           38408463         0.730                       356                      518
  CHD              NA18699      SDPR            serum deprivation response                                               2         192408894          192419896        0.720                       524                      1033
  JPT              NA18983      SPRR2G          small proline-rich protein 2 G                                           1         151388989          151389210        0.670                       81                       147
  JPT              NA19066      SPRR2G          small proline-rich protein 2 G                                           1         151388989          151389210        0.670                       105                      182
  JPT              NA19066      RBMS1           RNA binding motif, single stranded interacting protein 1                 2         160840394          160932124        0.670                       404                      642
  JPT              NA19054      EIF2B5          eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82 kDa   3         185500333          185509372        0.670                       869                      1470
  CHD              NA18695      RAN             RAN, member RAS oncogene family                                          12        129923334          129926424        0.660                       290                      539

###### 

Gene deletion calls in the BCM dataset

  **Population**   **Sample**   **Gene name**   **Gene function**                                       **Chr**   **Start \[bp\]**   **End \[bp\]**   **Posterior probability**   ***RD***~**observed**~   ***RD***~**expected**~
  ---------------- ------------ --------------- ------------------------------------------------------- --------- ------------------ ---------------- --------------------------- ------------------------ ------------------------
  LWK              NA19355      MBD5            methyl-CpG binding domain protein 5                     2         148932798          148986980        0.999                       618                      973
  CHD              NA17970      MTERFD2         MTERF domain containing 2                               2         241684086          241687982        0.996                       255                      393
  CHB              NA18618      GABARAPL2       GABA(A) receptor-associated protein-like 2              16        74159436           74168768         0.800                       58                       99
  CHD              NA18135      PSMB4           proteasome (prosome, macropain) subunit, beta type, 4   1         149638688          149640929        0.729                       390                      605

![**Detected CNV events. A**. Top-ranked (by posterior probability) deletion events in the SC dataset. **B**. Validation results for different callsets (left -- without neighboring information, right -- with use of neighboring information). Green denotes events positively validated either in our experiments or as known events \[[@B17]\]; red -- calls validated negatively in our experiments; yellow -- calls without validation status (not submitted for validation or validation experiments without conclusive outcomes). **C**. Detection sensitivity as a function of number of samples. **D.** Sensitivity of detecting common CNV as a function of the deleted allele frequency.](1471-2105-13-305-3){#F3}

When two or more gene deletions are detected in close proximity, it is likely that these events are part of a single, longer genomic deletion spanning the genes. With this in mind, we searched the sequenced genes for deletion events at a lower probability cutoff value (*h*= 0.1), but required that an immediate neighbor of a candidate gene be located within 3 Mbp and also show evidence for a deletion at the same probability cutoff. This procedure produced 17 heterozygous deletion calls in the SC dataset, 11 calls in the BI dataset (but no such calls were made in the BCM dataset). The union of both callsets (i.e. those made with and without use of neighboring information) resulted in a total of 107 unique deletion events (41 in SC dataset, 62 in BI, and 4 in BCM).

We note that none of the events we detected in our data were at high allele frequency. In fact, even the most "common" events were only present in two samples, as heterozygotes.

Call-set accuracy assessment
----------------------------

To assess the accuracy of deletion calls made in the SC dataset, we performed experimental validations on calls made with posterior probability ≥ 0.65 without neighbor information, using qPCR (see Methods). The validation results are summarized in Figure [3](#F3){ref-type="fig"}B. Of the 36 calls made, we evaluated 26. All 22 calls with posterior probability ≥ 0.95 and 4 out of 12 calls (randomly selected) with posterior probability between 0.65 and 0.95 were submitted for validation. 6 were considered positively validated as they appeared in an earlier publication \[[@B17]\] and 20 were validated *de novo* using qPCR. The qPCR validations produced positive results for 12 calls (measured fold change \< 0.7) and negative results for 3 calls (measured fold change \> 0.8). The validation results for the remaining 5 were inconclusive. All the 17 neighbored calls with posterior probability ≥ 0.1 were selected for validation. 7 were considered valid per previous publication \[[@B17]\], 7 were positively validated *de novo* and none was found invalid; validation was not obtained for the remaining 3. The union of those two callsets counted 41 calls and 32 of them were evaluated. Among these 32 calls 7 were considered positively validated per previous publication \[[@B17]\], 14 were positively validated *de novo*, 3 were invalidated, 5 were inconclusive and 3 did not obtain the validation results. The numbers of validated calls are presented in Table [7](#T7){ref-type="table"}. The selection procedure for site validation was as follows: (1) We selected sites for validation (in some categories, all candidates, in others, a random selection); (2) we searched the literature, and removed from the validation list events that we found as validated in one of the publications we consulted; (3) events that remained on the list were sent for experimental validation. The overall FDR for the union of calls made with and without neighboring information can be estimated as 12.5% (3/24).

###### 

Validation results

                                                                             **Posterior ≥ 0.95 without neighbor information**   **0.65 ≤ Posterior \< 0.95 without neighbor information**   **Posterior ≥ 0.1 with neighbor information**
  -------------------------------------------------------------------------- --------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------
  **Validated per previous publication**                                     4                                                   2                                                           7
  **Validated positively de novo**                                           11                                                  1                                                           7
  **Validated inconclusively de novo (intermediate fold change)**            4                                                   1                                                           0
  **Validated negatively de novo**                                           3                                                   0                                                           0
  **Submitted for validation but without result or no validation attempt**   0                                                   10                                                          3
  **Total calls**                                                            22                                                  14                                                          17

Sensitivity
-----------

We performed simulations to assess the detection efficiency of our method, both for individual gene and for pairs of neighboring genes deletions. Specifically, in each sample we randomly selected (a) 5 out of 862 genes in one simulation and (b) 5 pairs of neighboring genes in another simulation. In the selected genes we down-sampled the actual read depth seen in the experimental data by a factor of 2 to simulate a heterozygous deletion. The results of those simulations are presented in Figure [3](#F3){ref-type="fig"}C. Of the 530 gene deletions, we detected 237 (45%). Of the 530 gene-pair deletions we detected 287 (54%). We also performed simulations on smaller subsets of the original 106 samples to assess the impact of sample size on detection sensitivity. Reduction of sample size did not substantially degrade detection sensitivity as long as the number of samples was \>20. Therefore, our detection efficiency is 40-45% without using neighboring information and approximately 50-55% with the use of neighboring information, in the SC dataset.

In addition to simulations, we compared our dataset to a published study \[[@B17]\]. This study reported 12 heterozygous deletion events in samples and genes (in our terminology, GSS) that were part of our analyzed dataset. We detected 6 of these 12 events, which is broadly consistent with our overall sensitivity estimate.

Finally, we investigated our sensitivity to common events (see Methods) using simulations. Figure [3](#F3){ref-type="fig"}D shows detection sensitivity as a function of gene-level affinity: for a gene affinity value of 1.8 (representing the 75^th^ percentile of our data), sensitivity to common events (allele frequency between 10% and 90%) approaches 40%. Note that the detection efficiency starts to decrease at high allele frequency (\> 70%) due to a reduction of the overall read depth because more samples have a deletion and a corresponding depleted read depth signal. We can also see that the median gene affinity is substantially lower than the mean because the distribution of gene affinity has a long tail at the high end (Figure [2](#F2){ref-type="fig"}D). Since sensitivity is directly related to the gene affinity, the simulated data with the substantially higher mean gene affinity (red) has better sensitivity than with the substantially lower median gene affinity (green).

The number of CNV events in the samples
---------------------------------------

We estimated the total number of gene deletions in the SC dataset from the number of detected events (41), the FDR (12.5%) and the detection efficiency (45%), as \~66, or a nominal 0.62 deletions per sample. By projecting the per-sample number, corresponding to 3.9% of the exome (862 genes of 21,999), onto the whole exome, our estimate for the average number of genic deletion events is 16 ± 4 per sample. This estimation is representative for the whole-exome sequencing data since the 1000 Genomes Exon Pilot Project randomly selected all the exon targets from the CCDS collection. Our gene set is therefore a quasi-random sampling of known human genes, with no intentional enrichment for any given gene family. Figure [4](#F4){ref-type="fig"}A and B show the distributions of exon length in the gene list used for our analysis and the full human exome. There is no significant difference between these two distributions: the median and the standard deviation of the exon length for our study are 125 bp and 236 bp, whereas the corresponding values for the whole exome are 127 bp and 264 bp. The similarity of these two distributions suggests that our estimation of the number of events per sample is unbiased and is representative for a whole-exome analysis.

![**Exon length distribution. A**. Exon length distribution in the gene list used for our analysis. (median: 125 bp, standard deviation: 236 bp) **B**. Exon length distribution of the whole exome. (median: 127 bp, standard deviation: 264 bp) These two distributions are very similar to each other, suggesting our estimation of the number of events per sample is unbiased and is representative for a whole-exome study.](1471-2105-13-305-4){#F4}

Detection efficiency as a function of data quantity and data quality
--------------------------------------------------------------------

As discussed earlier, our algorithm's sensitivity was \~45% at \~87.5% accuracy. Both sensitivity and accuracy are considerably lower than achievable for SNP detection in the same datasets \[[@B16]\]. This poses the more general question of how detection efficiency is influenced by sample size, data quantity, and data quality. Our simulations show that sensitivity only modestly depends on sample size, above approximately 20 samples (Figure [3](#F3){ref-type="fig"}C).

We found that the primary factors that determine detection efficiency are (i) sequence coverage, or more precisely, RD (higher RD supplies more statistical power to detect systematic changes in coverage); (ii) the level of over-dispersion of the RD distribution for individual genes (the more the RD distribution departs from an expected Poisson distribution, the less one can rely on the statistics); and (iii) the shape of the distribution of RD across all genes in the dataset, determined by the gene affinities (uneven distribution means that detection power is low in a high fraction of the genes, but this effect is not compensated by the extra coverage in other, "over-sequenced" genes where detection efficiency is already high, see Figure [5](#F5){ref-type="fig"}A below. Favorable scenarios therefore involve distributions in which all or most genes have sufficient RD for detection).

![**Detection efficiency. A**. Distributions of the detection efficiency estimated from the quality index for each gene-sample site. **B**. Theoretical detection efficiency (at posterior probability cutoff *h*= 0.65) as a function of expected read depth, plotted for various values of the over-dispersion factor. **C**. Histograms of the quality index (QI) distribution in the three datasets. Overall, QI was highest in SC: 9.4±8.8 (median 6.6); second highest in BI: QI = 7.6 ± 5.6 (median 6.2); and lowest in BCM: QI = 5.5 ± 2.3 (median 5.0).](1471-2105-13-305-5){#F5}

For each gene, we compute a quality index (QI) taking into account the variance of the expected read depth for that gene (assuming the ideal, Poisson distribution), *RD*~exp~, and a over-dispersion factor, ODF, that quantifies the over-dispersion of RD relative to the Poisson expectation:

$$QI = \frac{\sqrt{RD_{\text{expected}}}}{ODF}$$

QI is directly related to detection sensitivity (see Additional file [1](#S1){ref-type="supplementary-material"} for the exact formula and its derivation), as shown in Figure [5](#F5){ref-type="fig"}B. According to our power calculations, for the posterior detection threshold value we used in this study (*h*= 0.65), sensitivity is completely diminished for genes with QI \< 5.1. QI ≥ 7.2 is required to achieve 50% sensitivity, and QI ≥ 9.5 to achieve 90% sensitivity. This estimated sensitivity from QI is made only for heterozygous deletions. To achieve the same sensitivity for detecting higher copy number variation (CN≥3), higher QI value will be required since the difference of prior probability between higher copy and normal copy (CN=2) is greater than that between heterozygous deletion and normal copy (Table [8](#T8){ref-type="table"}).

###### 

**Nominal prior probabilities corresponding to the range of gene region copy numbers derived from Conrad et al.**\[\[[@B17]\]\]

  **Copy number**   **Prior probability per gene**
  ----------------- --------------------------------
  0                 6.34·10^-4^
  1                 2.11·10^-3^
  2                 9.96·10^-1^
  3                 5.38·10^-4^
  4                 6.68·10^-4^
  5                 3.57·10^-5^
  6                 7.52·10^-6^
  7                 1.39·10^-6^
  8                 3.61·10^-7^
  9                 4.37·10^-8^

The distributions of QI values in our three datasets are shown in Figure [5](#F5){ref-type="fig"}C. Overall, QI was highest in SC: 9.4 ± 8.8 (median 6.6); second highest in BI: QI = 7.6 ± 5.6 (median 6.2); and lowest in BCM: QI = 5.5 ± 2.3 (median 5.0). The corresponding distributions of detection efficiency values are shown in Figure [5](#F5){ref-type="fig"}A. Because detection efficiency increases abruptly from 0 to almost 1 over a narrow range of QI values (note the mapping between the vertical axes in Figure [5](#F5){ref-type="fig"}B), the distribution of detection sensitivity (Figure [5](#F5){ref-type="fig"}A) is strongly bimodal, with the vast majority of GSS having either close to zero or close to 100% sensitivity. Even in the SC dataset with the highest overall QI values, in less than half of the GSS does the quantity and quality of the data support \>80% detection efficiency. There was also very substantial variation across samples: only 15 of the 106 SC samples had sufficiently high coverage to support ≥ 90% overall sensitivity, and in 22 samples overall sensitivity was below 10%.

Given that QI improves only with the square root of RD, over-dispersion can profoundly influence detection performance, as shown in Figure [5](#F5){ref-type="fig"}B. The ODF values we chose for this figure correspond to the 25^th^, 50^th^ and 75^th^ percentile, and the mean values (ODF=3, 5.5, 10, and 8, respectively) in the SC dataset. Using the observed distribution of QI in the SC dataset, we predict \~46% sensitivity, in good agreement with our estimate based on simulations.

The QI formulation permits one to estimate CNV (or specifically in our case, heterozygous deletion) detection power in any given exon capture dataset, based on the read mappings. One can also use the formulation to calculate the amount of base coverage required for a given level of desired power, to guide data collection. For example, using the distributions of QI values in the SC dataset, one would need to collect an overall 110× coverage, assuming 36 bp reads, to achieve 60% detection power, and 320× coverage to achieve 80% detection power. However, if DNA capture methods improved to support a median ODF=3, assuming an accordingly scaled version of the observed distribution of QI in the SC dataset, one would only need to collect 33× coverage for 60% power, and 96× for 80% power. It is important to also point out that, in the case of whole-exome data, sensitivity would also improve just by virtue of the higher density of targeted genes, if one were to integrate in one's pipeline neighbor-gene based detection.

Methodology comparison with CoNIFER
-----------------------------------

Krumm and his colleagues recently published a method, CoNIFER \[[@B18]\], that also used read-depth signal to detect CNV in the exome capturing sequencing data. Like our method, CoNIFER normalizes the read depth signal in order to discover the CNV. However, it is quite different for these two algorithms in the approach of calling samples copy number variants on the basis that they present aberrant read depth. As we mentioned previously, our method deploys specific models for copy numbers 0, 1, 2, and is capable of detecting both rare, intermediate frequency, and common CNV events. On the other hand, CoNIFER deploys singular value decomposition (SVD) to remove noise from the read depth data, and interprets the first "k" singular values as noise in the data. This approach may identify systematic variance in the data caused by a high-frequency CNV event as noise and removes it. Therefore CoNIFER has limited power for detecting common CNV events. On the other hand, our method is capable of detecting CNV events on the entire frequency spectrum, and is therefore more generally applicable.

Conclusions
===========

We have developed a novel, Bayesian method to identify CNVs in exon-capture data. We applied this method (and a simple extension using neighbor-gene information) to the 1000 Genomes Project Exon Sequencing Pilot dataset. We were able to achieve reasonable sensitivity and specificity in a dataset that was optimized for SNP discovery and, as discussed above, is far from ideal for CNV detection. The main accomplishment of this work is that we provide a statistically rigorous algorithm for CNV detection in exon capture data, backed by experimental validations, that can be applied to the thousands of exomes sequenced to date in various medical projects, and to nascent and ongoing projects targeting increasingly higher numbers of samples. Our formulation allows investigators to assess detection power in existing datasets and to take into account CNV detection power during experimental design for future datasets. We also uncovered \>100 heterozygous deletion events in the 1000 Genomes samples we examined, allowing us to estimate the average number of heterozygous deletions per exome (as \~16 events per exome). Because we focused on algorithm development functional assessment of these sites is beyond the scope of this study. Nevertheless, these and other gene deletions that will be found using our methods are very likely to uncover events with strong functional significance.

Methods
=======

The overall detection workflow (shown in Figure [1](#F1){ref-type="fig"}) consists of three main steps. (1) We tabulate the *observed* read depth for every GSS. (2) We determine whether the distribution of read depth for a specific gene distribute across samples should be modeled using simple uni-linear fit or using a more sophisticated tri-linear fit. (3) If the simple uni-linear fit is found suitable, we determine an *expected* read depth for every GSS under a null hypothesis of a normal copy number, using a simple linear fit model. (4) Subsequently, we compare the observed read depth for a GSS to the corresponding expectation and calculate a Bayesian posterior probability for each copy number considered (CN=0-9), threshold these, and report events with a non-normal CN. (5) If data do not allow for modeling using a simple uni-linear fit model, we perform a more sophisticated tri-linear fit. The tri-linear fit directly assigns copy number to every sample.

Observed read depth
-------------------

Capture sequencing reads from the 1000 Genomes Project Exon Sequencing Pilot Project were downloaded, in FASTQ format, from the 1000 Genomes Project DCC site: <http://1000genomes.org>. The reads were mapped using the MOSAIK read mapping program, to the NCBI build 36.3 human reference genome. The resulting read alignments (in BAM format) were further processed to remove duplicate reads, and reads with low mapping quality (\<20).

Gene target regions were also downloaded from the 1000 Genomes Project site. For each GSS, we determined RD as the number of distinct reads that had their first (5') base uniquely mapped within an exon of that gene. This resulted in a matrix of RD observations (illustrated in Figure [1](#F1){ref-type="fig"}C left).

Data filtering
--------------

We discarded all duplicate reads and all reads with mapping quality less than 20. We also discarded all the targets with median RD less than 30. Similarly, we discarded all the samples with median RD less than 30. In 454-sequenced data, this led to discarding almost all targets and samples; therefore we relaxed those criteria to 5 and 1, respectively. Additionally, we discarded all the genes that failed to exhibit correlation between observed RD and MRD at *r*^2^ ≥ 0.7.

Expected read depth based on uni-linear fit and tri-linear fit
--------------------------------------------------------------

In the first attempt, we use the simple uni-linear fit; we calculate the expected read depth for normal copy number (CN=2) as the product of a gene-specific capture affinity value, α~g~, and a sample-specific measure of read coverage, the median of read depths, *MRD*~s~, across all genes for that sample:

$$RD_{\mathit{gs}} = \alpha_{g}.MRD_{s}$$

The gene-specific capture affinity (α~g~) is determined as the slope of a least-squares zero-intercept linear fit between the gene-specific read depth (*RD*~gs~) and the median read depth (*MRD*~s~) for all samples (illustrated in Figure [1](#F1){ref-type="fig"}B). This procedure resulted in a matrix of RD expectations (Figure [1](#F1){ref-type="fig"}C right).

The afore-mentioned procedure requires a single-line linear fit between *RD*~gs~ and *MRD*~s~. The quality of such a fit is evaluated by comparing *r*^2^ against a predetermined threshold (≥ 0.7 as described before). When this indicates poor quality of the single-line linear fit, we attempt to perform a tri-linear fit.

Briefly, we attempted to minimize error function

$$\text{erro}r_{g} = {\sum\limits_{s}{\text{min}\left\{ {\left( {RD_{g,s} - \alpha_{g}MRD_{s}} \right)^{2},\left( {RD_{g,s} - \frac{\alpha_{g}}{2}MRD_{s}} \right)^{2},\left( {RD_{g,s} - 0.MRD_{s}} \right)^{2}} \right\}}},$$

where *s* iterates over samples and g indicates the gene in question. Note that the tri-linear fit directly assigns copy number to each GSS. Please see Common CNVs for more detail.

Copy number probabilities
-------------------------

We used a Bayesian scheme to calculate the probability P(*CN*~*gs*~*\|RD*~*gs*~ of a given copy number at a given GSS, based on the observed read depth. We only considered CN=0-9 i.e. homozygous deletion (CN=0), heterozygous deletion (CN=1), normal copy number (CN=2), and amplifications of various magnitudes (CN\>2). We assigned prior probabilities P(*CN*~gs~) to each copy number based on CNV events reported in an earlier study \[[@B17]\] (Table [8](#T8){ref-type="table"}). We assumed that, for each distinct CN, the observed RD obeys an over-dispersed Poisson distribution. Its mean value for normal copy number (CN=2) is calculated according to (Eq. 2) and for other copy numbers it is proportionally scaled. The standard deviation of the distribution includes an over-dispersion factor (ODF) in the range of 1 to 20 to account for over-dispersion (variance beyond the level of Poisson fluctuations, see Additional file [1](#S1){ref-type="supplementary-material"}).

Briefly, to account for over-Poisson dispersion, we used observed RD~gs~ and calculated corresponding *z*-score under an assumption of an ideal Poisson distribution at every GSS. Subsequently, we calculated a sample-specific standard deviation of that *z*-score for every sample and annotated it as sample over-dispersion factor. Similarly, we calculated a gene-specific standard deviation of *z*-score for every gene and annotated it as the gene-specific over-dispersion factor. If the assumption of an ideal Poisson distribution were true, those sample- and gene-specific standard deviations should equal 1. Subsequently, we calculated the over-dispersion factor for every GSS as a product of respective sample- and gene-specific ODFs. The ODF was then normalized and assigned to 1 if less than 1.

We used the over-dispersed Poisson distributions to calculate the data likelihoods P(*RD*~gs~\|*CN*) for all considered CN values. Finally, we used Bayes' method to estimate the posteriors for each considered CN. A CNV event is reported the posterior probability of a non-normal copy number is above a pre-defined threshold value, *h*.

Neighboring gene deletions
--------------------------

A simple extension of the algorithm used neighboring gene deletion events as part of the detection method. For the purpose of our algorithm, the genes were deemed "neighboring" if they were located on the same chromosome, the segment between those genes was no longer than 3 Mbp and no gene was sequenced in between. In principle, when a gene has a deleted neighbor, we should assume a higher prior probability of a deletion in the gene in question. Since the posterior probability usually scales monotonically with the prior, for practical reasons we assumed a lower Bayesian posterior probability threshold (*h*= 0.1) to produce a preliminary list of candidate events. Events on this list for which at least one of the two immediate neighbor genes was also on the list were retained.

Sensitivity estimation
----------------------

We carried out sensitivity estimation in the SC dataset, using simple simulations. In each simulation cycle, we drew 5 genes randomly from every sample, and downscaled the observed RD for those genes by a factor of 2, to emulate heterozygous deletions. We then applied our standard detection procedure to this "spiked" dataset, and tabulated the fraction of simulated events that were detected by the algorithm.

Common CNVs
-----------

We evaluated all genes that failed to achieve *r*^2^ ≥ 0.7 using the linear fit model from Figure [1](#F1){ref-type="fig"}B. The results of that evaluation are shown in Figure [6](#F6){ref-type="fig"}. The last row describes result for gene RNF150 that achieved the worst *r*^2^ of 0.48. The histogram shown in the left columns demonstrates distribution of observed RD to MRD (taken as from Figure [1](#F1){ref-type="fig"}B), In case of a rare CNV (or lack of CNVs at all), one would expect a unimodal distribution centered around that gene affinity. For a common CNV, one additional peak corresponding to CN=1 centered around half of that gene affinity, and another peak corresponding to homozygous deletion (CN=0) around 0, should be visible. However, the data shown do not allow identifying such a pattern of either bi- or tri-modal distribution.

![**Analysis of genes that failed simple linear fit.**Each row describes a different gene. Left panels -- distribution of the ratio of RD at the GSS sites to the sample MRD. Right panels -- distribution of the quality index for that gene. The non-multimodal distributions and the low quality-index values of these genes suggest that there are no common CNV events on these loci.](1471-2105-13-305-6){#F6}

Additionally, the histogram of quality index calculated for that gene is presented in the right column. The low values of quality index further corroborate the conclusion that the absence of a call in that locus is due to lack of high quality data rather than due to a hypothetical common CNV event. Careful inspection of the graphs calculated for all 69 genes the failed simple linear fit reveals lack of evidence for a common CNV in any of them. Notably, in the SC dataset only 28% of GSS in genes with *r*^2^ \< 0.7 were potentially detectable vs. 62% in genes with *r*^2^ ≥ 0.7.

With no common CNV present in the experimental data, we tested the sensitivity of our algorithm using simulated deletions. We used realistic gene affinities (mean and three quartiles from Figure [2](#F2){ref-type="fig"}B) and the empirical MRDs for 106 samples. We assumed frequency of the deleted allele among 106 samples varying from 0 to 100% in 10% increments; we allowed for random segregation, so that both homo- and heterozygous deletions were introduced. Then for each sample we calculated the expected read depth as a product of MRD and affinity; however in the samples drawn for a heterozygous deletion we used halves of the nominal affinities and in the samples drawn for a homozygous deletion, we multiplied the MRD by 0.01 to account for reads erroneously mapped into that region. Having an expected read depth *m* for each sample, we drew a random read depth using a normal distribution $N\left( {m,ODF\sqrt{m}} \right)\sqrt{2}$, where ODF was assumed 8.

In Figure [7](#F7){ref-type="fig"}B and C we show the results of analysis performed on simulated common CNV events. Panel B shows *r*^2^ values obtained from the simple linear fit (as in Figure [1](#F1){ref-type="fig"}B) and panel C shows the *r*^2^ values obtained from the tri-linear fit (as in Figure [7](#F7){ref-type="fig"}A). The uni-linear *r*^2^ values deteriorate with the increase of the deleted allele frequency. To the contrary, the tri-linear *r*^2^ values stay relatively high over wide range of the allele frequency.

![**Simulated Common CNVs. A.**If a simple linear fit fails, the gene affinity is estimated for each gene as the slope of the least-square-error tri-linear fit between MRD and RD for that gene. **B** and **C***r*^2^ values of a simple linear fit (**B**) and a tri-linear fit (**C**) as a function of the deleted allele frequency.](1471-2105-13-305-7){#F7}

Finally, Figure [3](#F3){ref-type="fig"}D demonstrates that the sensitivity of the algorithm to the common CNVs remains relatively stable over wide range of the deleted allele frequency (up to 90%).

Validation experiments
----------------------

All primers were designed using primer3 (<http://fokker.wi.mit.edu/primer3/>) with default settings to obtain a desired PCR amplicon size between 200 bp and 250 bp. All primers were checked with BLAT (<http://genome.ucsc.edu/>) to avoid known SNPs that could influence primer hybridization. PCR products were run on an agarose gel to make sure they gave no additional bands besides the expected amplicon.

Primer efficiencies were determined by calculating the standard curve of a serial dilution (4 times, 10-fold) of pooled genomic DNA (Promega, Madison, WI). All experiments were performed in triplicates on the Roche LightCycler 480 platform with LightCycler 480 SYBR Green I Master (cat\# 04707516001). The volume of each reaction was 20 μl with final primer concentrations of 400 nM. The PCR was performed according to the following protocol: 5 min at 95°C, 2. 45 cycles of 5 s at 95°C, 10s at 60°C, 30s at 72°C. To determine the copy number state of an event locus, we used the Delta-Delta-Ct-Method (2-ΔΔCt) for each event locus compared to a reference locus in the sample and a control pool of seven individuals (Promega, Madison, WI), respectively. This reference locus was not previously known to show any copy number variation.

Among the calls made without neighboring information, we exhaustively validated all the calls with posterior probability of 0.95 or more (4 coincided with known events \[[@B17]\]; we experimentally validated the remaining 18 events). Additionally, we performed qPCR validations for 4 events randomly selected from those with posterior probability between 0.65 and 0.95 (2 coincided with known events \[[@B17]\]; we experimentally validated the remaining 2 events).

Of the calls made with the neighboring information, we deemed 7 calls coincided with known events \[[@B17]\]; 7 out of 10 remaining calls were submitted for qPCR validation. For the purpose of validation, the fold change for a given gene \< 0.7 was classified as a positive validation, \> 0.8 as a negative validation and in the intermediate range as inconclusive.
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